search
for
 About Bioline  All Journals  Testimonials  Membership  News


European Journal of General Medicine
Medical Investigations Society
ISSN: 1304-3897
Vol. 4, Num. 1, 2007, pp. 33-35

European Journal of General Medicine, Vol. 4, No. 1, 2007, pp. 33-35

A RARE PRESENTATION ON EBV HEPATITIS

Tuna Demirdal, Neşe Demirtürk

Afyon Kocatepe University, School of Medicine, Department of Infectious Disease and Clinical Microbiology, Afyon, Turkey
Correspondence: Dr. Tuna Demirdal, Kocatepe Üniversitesi Tıp Fakültesi, İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji A.D. 03200- Afyonkarahisar / Türkiye, Tel: 902722142065-66/1118, E-mail:tunademirdal@hotmail.com

Code Number: gm07007

Epstein-Barr virus is a member of Herpesviridae family and it is the cause of infectious mononucleosis (IM) disease. While 50% of the patients having IM have high serum aminotransferases, clinically, a real hepatitis is seen rarely. Presentation of IM with hepatitis clinic without its other symptoms is not a common condition. Jaundice is especially uncommon so it isn’t the presentation symptom generally. When making the differential diagnosis of acute hepatitis, peripheral blood smear examination was crucial, in order toreveal atypical lymphocytes suggesting IM. In this report we presented a patient with icteric IM hepatitis who have atypical lymphocytes on his peripheral blood smear.

Key words: Epstein-Barr virus hepatitis, infectious mononucleosis, atypical lymphocytes

INTRODUCTION

Epstein Barr virus (EBV) is a member of the herpesviridae family and one of the most common human virus. It has been established as the etiological agent of infectious mononucleosis (IM). IM is common worldwide in distrubution and appears in all age groups especially late adolescents or early adulthood. It is largely subclinical in early childhood. In addition EBV appears to play an important role in Burkitt’s lymphoma and nasopharyngeal carcinoma. Largely of self-limited elevations of hepatocellular enzyme levels are shown present in 90 percent of the cases of EBV infection-induced IM but EBV causes acute hepatitis rarely. Jaundice is distinctly uncommon so it isn’t presentation symptom generally. The jaundice is seen 5 percent of the cases (1,2). We describe in a patient who presented with jaundice due to serologically confirmed acute infection with EBV.

CASE

A 20 years old male patient who had weakness, fatigue, yellowness of sclera and right hipocondrium pain for two weeks admitted to the Infectious Disease clinic. He had no significant past medical history. Jaundice of sclera and skin and tenderness of fist percussion over the liver were found on physical examination. Laboratory studies showed midly elevated levels of alanine aminotransferase (165 U/L), aspartate aminotransferase (60 U/L), gamma glutamile transferase (118 U/L), conjugated bilirrubine (1.6 mg/dl), total bilirrubine (4 mg/dl) and normal level of alkaline phosphatase (272 U/L). The hemogram was found normal. Serological markers for hepatitis A, B, C, D and CRP were negative. Protrombine time was normal. Brucella agglutination tests (Rose Bengal and Wright) and Gruber Widal were negative. Because the patient refused hospitalization, he was told to rest at home. He returned to the clinic seven days later. He had had the additional complaint of a sore throat for past two days. His temperature was 37 0C. Jaundice of sclera and skin, hepatomegaly and erythema on phrynx were found on physical examination. Laboratory studies did not show important alteration. Ultrasonography (USG) of abdomen showed reduced echogenity on the liver. The hemogram showed normal white blood cell (10x103 /mm3 )but 15 % atypical lymphocytes. Serological markers for CMV (anti-CMV IgM ve IgG) were negative but EBV (anti-EBV VCA IgM and IgG, Paul Bunnel and monospot tests ) were positive. So the diagnosis of HBV hepatitis was established. He was told to rest at home for ten days and to come again for a control. He returned to the clinic 15 days later. The following results were revealed: ALT: 35 U/L, AST: 25 U/L, ALP: 250 U/L, conjugated bilirrubine 0.5 mg/dl, total bilirrubine 1.2 mg/dl and white blood cell count 7840/mm3. No atypical lymphocytes were seen on the hemogram.

DISCUSSION

EBV infection is common all over the world. In the United States 50 % of the children up to the age of five and 95 % of adults carry the disease. In children these infections usually cause no symptoms. When the infection with EBV occurs during adolescents or young adulthood it causes IM at the rate of 35 % to 50 %. Classic EBV infection-induced IM usually begin with weakness, sweats, anorexia and myalgias. This period is called the prodrome period and lasts several days. Then fever, sore throate and swollen lymph glands develops. In 50 % of the cases splenomegaly and 10 % of the cases hepatomegaly may be detected (1-3).

In our patient first symptoms were weakness and jaundice. So we didn’t think IM at first application. But seven days later sore throat and atypical lymphocytes on peripheral blood smear appeared so we thought IM. In patients with IM the lymphocyte count constitutes 50% of the total white blood cell count. Of this 10-30 % is atypical lymphocytes (4). In our patient’s peripheral blood smear were 55 % lymphomonocytosis and atypical lymphocytes. And then serological tests for EBV infection performed.The result of this tests were confirmed the diagnosis of IM. On four cases of EBV infection presented with jaundice, Albornoz et al. reported that the most useful laboratory finding was atypical lymphocytes (5). In adults and adolescents IM is frequently symptomatic (1). Our patient was an adult and IM was symptomatic in him, too. So in patients that presented with symptoms of jaundice, peripheral blood smear must be examined. We think this simple examination is very useful for diagnosis.

Posterior cervical adenopathy is present 80-90 % of the cases of IM (1). But we didn’t detect it on our patient. Likewise Albornoz et al, didn’t detect adenopathy on their four patients (5). Adenopathy does not occur in 10-20 % of the cases of IM so if other symptoms and signs are considered to cause IM, lack of adenopathy shouldn’t cause to avoid the diagnosis of IM.

Liver involvement is nearly universal in healthy persons with EBV infection-induced IM. But severe hepatitis as in two patients described by Ghosh et al, is uncommon (6). Presentation of IM with only jaundice and hepatitis and without other symptoms is very rare. Cholestatic hepatitis due to EBV infection is infrequently reported (4,7,8). IM began on our patient with jaundice, weakness and right hipocondrium pain and didn’t lead to cholestatic and fulminant hepatitis. It was self-limited. However, patients at older ages should be closely examined considering the fulminant hepatitis and long-term cholestasis (9,10).

In conclucion; in differential diagnosis of jaundice and hepatitis, IM associated EBV hepatitis should be keep in mind. The patient may not have typical symptoms for IM and may have only hepatitis clinic. In a condition as above, IM should be taken into consideration even if physical examination results aren’t parallel. So, peripheral blood smear must be examined carefully while drawing a result.

REFERENCES

  1. Johannsen EC, Schooley RT,Kaye KM. Principles and Practice of Infection Diseases. 5th ed. In Mandell GL, Bennet JE, Dolin R ed. Epstein Barr Virus (Infectious Mononucleosis). Philadelphia: Churchill Livingstone, 2005:181-20
  2. Andersson JP. Clinical aspects on EBV infetion. Scand J Infect Dis Suppl 1991;80:94-104
  3. Rubinstein E, Levi I, Rubinovitch B. Infectious Diseases. 1st ed. In Armstrong D, Cohen J ed. Generalized and Regional Lymphadenopathy. London: Mosby, 1999: sec.2.9
  4. Arman D. Infectious diseases and microbiology, 2nd ed. In Topçu AW, Soyletir G, Doganay M ed. Epstein-Barr Virus Infektionsi (Infektious mononucleousis). İstanbul: Nobel Tıp Bookstores, 2002:696-701
  5. Albornoz V, Wainstein E, Andrade A, Reyes H. Hepatitis by infectious mononucleosis. Rev Med Chil 1991; 119:1109-14
  6. Ghosh A, Ghoshal UC, Kochhar R, Ghoshal P, Banerjee PK. Infectious mononucleosis hepatitis: report of two patients. Indian J Gastroenterol 1997 ;16:113-4
  7. Hinedi TB, Koff RS. Cholestatic hepatitis induced by Epstein-Barr virus infection in an adult. Dig Dis Sci 2003;48:539-41
  8. Jacobson IM, Gang DL, Schapiro RH. Epstein-Barr viral hepatitis: an unusual case and review of the literature, Am J Gastroenterol 1984;79:628-32
  9. Edoute Y, Baruch Y, Lachter J, Furman E, Bassan L, Assy N. Severe cholestatic jaundice induced by Epstein-Barr virus infection in the elderly. Gastroenterol Hepatol 1998;13: 821-4
  10. Markin RS, Linder J, Zuerlein K, Mroczek E, Grierson HL, Brichacek B, Purtilo DT. Hepatitis in fatal infectious mononucleosis. Gastroenterology 1987; 93:1210-7

Copyright 2007 - Medical Investigations Society

Home Faq Resources Email Bioline
© Bioline International, 1989 - 2024, Site last up-dated on 01-Sep-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Google Cloud Platform, GCP, Brazil